首页> 外国专利> Composition comprising N-acetylcysteine and/or microencapsulated gastroprotected lysozyme in association with probiotic bacteria capable of restoring the stomach's own barrier effect which is lost during the pharmacological treatment of gastric hyperacidity

Composition comprising N-acetylcysteine and/or microencapsulated gastroprotected lysozyme in association with probiotic bacteria capable of restoring the stomach's own barrier effect which is lost during the pharmacological treatment of gastric hyperacidity

机译:包含N-乙酰半胱氨酸和/或微囊化的胃保护的溶菌酶以及能恢复胃自身酸性的药物,所述益生菌能够恢复在胃酸过多的药物治疗过程中丧失的胃自身的屏障作用

摘要

The present disclosure refers to a composition with N-acetylcysteine and/or lysozyme; or N-acetylcysteine and microencapsulated gastroprotected lysozyme with pro biotic bacteria for use in the pharmacological treatment of gastric hyperacidity. Said composition is capable of restoring the stomach's own barrier effect, which is lost during the pharmacological treatment of gastric hyperacidity, and of minimizing the secondary effects due to said pharmacological treatment.
机译:本公开涉及具有N-乙酰半胱氨酸和/或溶菌酶的组合物;或N-乙酰半胱氨酸和微囊化的胃溶菌酶以及益生菌,用于胃酸过多的药理治疗。所述组合物能够恢复胃自身的屏障作用,该屏障作用在胃酸过多的药物治疗期间丧失,并且使由于所述药物治疗引起的次级作用最小化。

著录项

  • 公开/公告号US10028982B2

    专利类型

  • 公开/公告日2018-07-24

    原文格式PDF

  • 申请/专利权人 GIOVANNI MOGNA;

    申请/专利号US201214344021

  • 发明设计人 GIOVANNI MOGNA;

    申请日2012-09-10

  • 分类号A61K35/747;A61K35/74;A23L33/135;C12R1/225;A61K35/741;A61K35/744;A61K35/745;A61K31/198;A61K38/47;A61K45/06;A23L33;

  • 国家 US

  • 入库时间 2022-08-21 13:05:28

相似文献

  • 专利
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号